A pragmatic randomised controlled trial of the cost-effectiveness of palliative therapies for patients with oesophageal cancer

Not Applicable

Completed

• Conditions: Cancer (neoplasms): Oesophagus; Cancer; Oesophagus

• Registration Number: ISRCTN18914993
• Lead Sponsor: Department of Health (UK)

Brief Summary

2005 Results article in http://www.ncbi.nlm.nih.gov/pubmed/15717937 HTA monograph

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2001-09-30
• Study Start: 2003-04-25
• Last Update Posted: 21 November 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 217

Inclusion Criteria

Patients with oesophageal cancer

Exclusion Criteria

Not provided at time of registration.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Relief of symptoms, incidence of early and late complications and improvement in swallowing ability and quality of life. The study will also estimate the total treatment costs to the NHS and demonstrate any differences in clinical effectiveness as well as the most cost-effective palliative therapy for malignant dysphagia when all complications and cost of subsequent additional treatments are taken into account.

Secondary Outcome Measures

Name	Time	Method
ot provided at time of registration.